SavedAdd your journal

Journals / Anatolian Current Medical Journal / 2026 / Volume: 7 Issue: 2

The relationship between nutritional parameters and pregnancy outcomes in abortus imminens

Abortus İmminens'te Beslenme Parametreleri ve Gebelik Sonuçları Arasındaki İlişki

Gülşan Karabay(ANKARA ETLİK ŞEHİR HASTANESİ)0000-0003-2567-2850
Zeynep Şeyhanlı(ETLİK ŞEHİR HASTANESİ)0000-0003-3924-3723
Ahmet Arif Filiz(ETLİK ŞEHİR HASTANESİ)0000-0002-6137-0270
Betül Tokgöz Çakır(ETLİK ŞEHİR HASTANESİ)0000-0003-0202-4981
Gizem Aktemur(ETLİK ŞEHİR HASTANESİ)0000-0001-6824-881X
Nazan Vanlı Tonyalı(ETLİK ŞEHİR HASTANESİ)0000-0002-7284-6887
Umut Karabay(Gülhane Eğitim Araştırma Hastanesi)0000-0002-9632-360X
Salime Nur Afsar(ETLİK ŞEHİR HASTANESİ)0009-0008-8691-1468
Zehra Yılmaz(ETLİK ŞEHİR HASTANESİ)0000-0002-8719-1879
Pages
—
Publication Date
2025-03-21
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to explore its clinical utility.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Abortus imminens (AI) is defined as vaginal bleeding and/or pelvic pain before the 20th week of pregnancy.
📊
Key Findings & Data:It affects approximately 20% of pregnancies.
💡
Conclusion & Impact:Further studies are needed to explore its clinical utility.
🔬Design:Research Article
📍Scope:2022 Verileri
⚙️Variables:Abortus imminens · HALP score · nutrition

Abstract

Aims: Abortus imminens (AI) is defined as vaginal bleeding and/or pelvic pain before the 20th week of pregnancy. It affects approximately 20% of pregnancies. The HALP score, which integrates hemoglobin, albumin, lymphocyte, and platelet levels, is a marker of inflammation and nutritional status. This study investigates the association between the HALP score and AI and its potential role in predicting pregnancy outcomes. Methods: This retrospective study was conducted at Ankara Etlik City Hospital between September 2022 and March 2024. A total of 254 patients with AI and 260 controls were included. Data on maternal demographics and laboratory parameters, including hemoglobin, albumin, lymphocyte, and platelet levels, were collected. Statistical analyses were performed using SPSS 22.0, with significance set at p<0.05. Results: The HALP score was significantly higher in the AI group than in controls (p=0.002). However, no significant difference in HALP scores was observed between patients who experienced pregnancy loss and those who continued their pregnancies (p=0.350). Preterm birth, newborn intensive care unit admission, and respiratory distress were more frequent in AI cases. Conclusion: The HALP score is a practical and cost-effective tool for diagnosing AI. Further studies are needed to explore its clinical utility.

Özet

Amaç: Abortus imminens (AI), gebeliğin 20. haftasından önce vajinal kanama ve/veya pelvik ağrı olarak tanımlanır. Gebeliklerin yaklaşık %20'sini etkiler. Hemoglobin, albümin, lenfosit ve trombosit seviyelerini birleştiren HALP skoru, inflamasyon ve beslenme durumunu gösteren bir belirteçtir. Bu çalışmada, HALP skoru ile AI arasındaki ilişki ve gebelik sonuçlarını tahmin etmedeki potansiyel rolü araştırılmaktadır. Yöntemler: Bu retrospektif çalışma Eylül 2022 ile Mart 2024 tarihleri arasında Ankara Etlik Şehir Hastanesi'nde gerçekleştirildi. Toplam 254 AI hastası ve 260 kontrol dahil edildi. Maternal demografik verileri ve hemoglobin, albümin, lenfosit ve trombosit seviyeleri gibi laboratuvar parametrelerine ilişkin veriler toplandı. İstatistiksel analizler SPSS 22.0 kullanılarak yapıldı ve anlamlılık p<0,05 olarak belirlendi. Bulgular: HALP skoru AI grubunda kontrollerden anlamlı olarak daha yüksekti (p=0,002). Ancak AI tanısı alıp abort eden hastalar ile gebeliklerine devam eden hastalar arasında HALP skorlarında anlamlı bir fark gözlenmedi (p=0,350). AI vakalarında erken doğum, yenidoğan yoğun bakıma yatış ve solunum sıkıntısı daha sıktı. Sonuç: HALP skoru AI tanısı için pratik ve maliyet etkin bir araçtır. Klinik faydasını araştırmak için daha fazla çalışmaya ihtiyaç vardır.

🔖

Cite This Article

Karabay, G., Şeyhanlı, Z., Filiz, A. A., Çakır, B. T., Aktemur, G., Tonyalı, N. V., Karabay, U., Afsar, S. N., Yılmaz, Z. (2025). The relationship between nutritional parameters and pregnancy outcomes in abortus imminens. Anatolian Current Medical Journal, Volume: 7 Issue: 2. https://doi.org/10.38053/acmj.1627202

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (30)

  1. Usta CS, Atik TK, Ozcaglayan R, Bulbul CB, Camili FE, Adali E. Does the fibrinogen/albumin ratio predict the prognosis of pregnancies with abortus imminens? Saudi Med J. 2021;42(3):255-263. doi:10.15537/smj. 2021.42.3.20200695
  2. Balikoğlu M, Bayraktar B, Arici Yurtkul A, Özeren M. The effect of vaginal bleeding in early pregnancy on first trimester screening test, uterine artery doppler indices and perinatal outcomes. Med Rec. 2023; 5(2):393-399. doi:10.37990/medr.1196046
  3. Katar-Yildirim C, Tokmak A, Yildirim C, Erel O, Caglar AT. Investigation of serum thiol/disulphide homeostasis in patients with abortus imminens. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2018;31(18):2457-2462. doi:10.1080/14767058.2017.1344962
  4. Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol. 2004;190(3):745-750. doi:10.1016/j.ajog.2003.09.023
  5. Zhao Y, D’Souza R, Gao Y, et al. Progestogens in women with threatened miscarriage or recurrent miscarriage: a meta-analysis. Acta Obstet Gynecol Scand. 2024;103(9):1689-1701. doi:10.1111/aogs.14829
  6. Hanna LM, Habashi LN, Topouzada ST, El Shebini SM, Galal OM. Nutritional status and unfavourable pregnancy outcome in Egyptian women. Nutr Rep Int. 1989;39(6):1217-1226.
  7. Tommaselli GA, Di Spiezio Sardo A, Di Carlo C, et al. Do serum leptin levels have a role in the prediction of pregnancy outcome in case of threatened miscarriage? Clin Endocrinol (Oxf). 2006;65(6):772-775. doi: 10.1111/j.1365-2265.2006.02665.x
  8. Çendek BD, Bayraktar B, Körpe B, Üstün YE, Keski NL, Erel Ö. Ischemia-modified albumin levels in threatened abortion and missed abortion compared to healthy pregnancies. J Exp Clin Med. 2024;41(1):102-107.
  9. Hakeem LA, Bello YO, Obajimi GO, et al. Inflammatory cytokines in maternal serum between women with threatened miscarriage and normal pregnancy. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2024;164(1):255-261. doi:10.1002/ijgo.15009
  10. Isenlik BS, Sarica MC, Kaygun BC, Inal HA. An evaluation of serum blood parameters and amyloid a levels in pregnant women with threatened miscarriage. Am J Reprod Immunol N Y N 1989. 2024;91(3): e13829. doi:10.1111/aji.13829
  11. Calleja-Agius J, Schembri-Wismayer P, Calleja N, Brincat M, Spiteri D. Obstetric outcome and cytokine levels in threatened miscarriage. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2011;27(2):121-127. doi:10.3109/09513590.2010.487614
  12. Chen XL, Xue L, Wang W, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6(38):41370. doi:10.18632/oncotarget.5629
  13. Farag CM, Antar R, Akosman S, Ng M, Whalen MJ. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types. Oncotarget. 2023;14:153-172. doi:10.18632/oncotarget.28367
  14. Alshuweishi Y, Basudan AM, Alfaifi M, Daghistani H, Alfhili MA. Association of the HALP score with dyslipidemia: a large, nationwide retrospective study. Med Kaunas Lith. 2023;59(11):2002. doi:10.3390/medicina59112002
  15. Xu H, Zheng X, Ai J, Yang L. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023;114: 109496. doi:10.1016/j.intimp.2022.109496
  16. Ekinci F, Balcik OY, Oktay E, Erdogan AP. HALP score as a new prognostic index in metastatic renal cell cancer. J Coll Physicians Surg--Pak JCPSP. 2022;32(3):313-318. doi:10.29271/jcpsp.2022.03.313
  17. Acar O, Ayhan M, Demir B, Ekinci F, Aytac A, Erdogan AP. HALP score as a new prognostic factor for patients with metastatic bladder cancer. J Coll Physicians Surg--Pak JCPSP. 2023;33(12):1405-1409. doi:10.29271/jcpsp.2023.12.1405
  18. Sargin ZG, Dusunceli I. The effect of HALP score on the prognosis of gastric adenocarcinoma. J Coll Physicians Surg--Pak JCPSP. 2022;32(9): 1154-1159. doi:10.29271/jcpsp.2022.09.1154
  19. Rodgers SK, Chang C, DeBardeleben JT, Horrow MM. Normal and abnormal US findings in early first-trimester pregnancy: review of the society of radiologists in ultrasound 2012 consensus panel recommendations. Radiogr Rev Publ Radiol Soc N Am Inc. 2015;35(7): 2135-2148. doi:10.1148/rg.2015150092
  20. Soysal C, Sarı H, Işıkalan MM, et al. Role of the systemic immune-inflammation index in threatened abortion patients and predicting of abortion. J Obstet Gynaecol Res. 2023;49(7):1723-1728. doi:10.1111/jog. 15655
  21. Biyik I, Albayrak M, Keskin F. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in missed abortion. Rev Bras Ginecol E Obstet Rev Fed Bras Soc Ginecol E Obstet. 2020;42(5):235-239. doi:10.1055/s-0040-1709693
  22. Vecchié A, Bonaventura A, Carbone F, et al. Antiapolipoprotein A-1 autoantibody positivity is associated with threatened abortion. BioMed Res Int. 2020;2020:9309121. doi:10.1155/2020/9309121
  23. Mate A, Reyes-Goya C, Santana-Garrido Á, Vázquez CM. Lifestyle, maternal nutrition and healthy pregnancy. Curr Vasc Pharmacol. 2021; 19(2):132-140. doi:10.2174/1570161118666200401112955
  24. Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14(2):381-389. doi:10.1245/s10434-006-9093-x
  25. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214-2221. doi.org/10.1002/1097-0142(20010615)91: 12 3.0.CO;2-P
  26. Soykan Sert Z, Bertizlioğlu M. Predictive value of the HALP score for pre-eclampsia with severe features. Postgrad Med. 2024;136(4):468-473. doi:10.1080/00325481.2024.2359892
  27. Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first-trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860-867. doi:10.1097/AOG.0b013e3181b79796
  28. Basama FMS, Crosfill F. The outcome of pregnancies in 182 women with threatened miscarriage. Arch Gynecol Obstet. 2004;270(2):86-90. doi:10. 1007/s00404-003-0475-z
  29. Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG Int J Obstet Gynaecol. 2010; 117(3):245-257. doi:10.1111/j.1471-0528.2009.02427.x
  30. Ozdemirci S, Karahanoglu E, Esinler D, Gelisen O, Kayıkcıoglu F. Influence of threatened miscarriage on pregnancy and early postpartum period: a case-control report. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2015;28(10):1186-1189. doi:10.3109/14767058.2014.947577